1. Home
  2. DEI vs PTGX Comparison

DEI vs PTGX Comparison

Compare DEI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

SELL

Current Price

$9.82

Market Cap

1.9B

Sector

Real Estate

ML Signal

SELL

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

SELL

Current Price

$124.80

Market Cap

9.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DEI
PTGX
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
9.3B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
DEI
PTGX
Price
$9.82
$124.80
Analyst Decision
Hold
Strong Buy
Analyst Count
12
14
Target Price
$12.20
★ $182.36
AVG Volume (30 Days)
★ 1.8M
521.0K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 7.68%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 5.43
Revenue
★ $1,003,982,000.00
N/A
Revenue This Year
$1.79
$1,130.56
Revenue Next Year
$2.61
N/A
P/E Ratio
★ N/A
$24.21
Revenue Growth
★ 1.77
N/A
52 Week Low
$9.04
$77.00
52 Week High
$12.97
$160.81

Technical Indicators

Market Signals
Indicator
DEI
PTGX
Relative Strength Index (RSI) 43.78 33.41
Support Level $9.30 $94.48
Resistance Level $10.10 $143.61
Average True Range (ATR) 0.28 5.77
MACD -0.03 -1.13
Stochastic Oscillator 1.99 3.59

Price Performance

Historical Comparison
DEI
PTGX

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: